ZimVie Inc Ordinary Shares ZIMV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ZIMV is a good fit for your portfolio.
News
-
ZimVie to Report First Quarter Financial Results on May 8, 2024
-
ZimVie Announces Closing of Sale of Spine Business
-
ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference
-
ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
-
ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
-
ZimVie Announces Launch of Next-Generation TSX® Implant in Japan
Trading Information
- Previous Close Price
- $15.81
- Day Range
- $15.27–15.59
- 52-Week Range
- $6.52–20.91
- Bid/Ask
- $15.48 / $15.50
- Market Cap
- $421.38 Mil
- Volume/Avg
- 144,434 / 354,597
Key Statistics
- Price/Earnings (Normalized)
- 9.49
- Price/Sales
- 0.90
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 2,600
- Website
- https://www.zimvie.com
Comparables
Valuation
|
Metric
|
ZIMV
|
MMSI
|
SIBN
|
|---|---|---|---|
Price/Earnings (Normalized) | 9.49 | 24.38 | — |
Price/Book Value | 1.02 | 3.53 | 3.66 |
Price/Sales | 0.90 | 3.41 | 4.22 |
Price/Cash Flow | 12.03 | 19.90 | — |
Price/Earnings
ZIMV
MMSI
SIBN
Financial Strength
|
Metric
|
ZIMV
|
MMSI
|
SIBN
|
|---|---|---|---|
Quick Ratio | 0.84 | 3.81 | 8.01 |
Current Ratio | 2.78 | 5.45 | 9.01 |
Interest Coverage | −1.51 | 8.07 | −13.52 |
Quick Ratio
ZIMV
MMSI
SIBN
Profitability
|
Metric
|
ZIMV
|
MMSI
|
SIBN
|
|---|---|---|---|
Return on Assets (Normalized) | 14.12% | 9.43% | −8.97% |
Return on Equity (Normalized) | 31.63% | 14.77% | −12.61% |
Return on Invested Capital (Normalized) | 18.79% | 11.47% | −11.78% |
Return on Assets
ZIMV
MMSI
SIBN
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Dmspdgzx | Nwmsxsy | $185.4 Bil | |
SYK
| Stryker Corp | Hblxhtxw | Qwz | $128.2 Bil | |
BSX
| Boston Scientific Corp | Mkjnwfcs | Bqxxyl | $107.7 Bil | |
MDT
| Medtronic PLC | Fkfjrbsx | Xqrfdk | $105.2 Bil | |
DXCM
| DexCom Inc | Gqlcshfjw | Qhbl | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Grdwrjwtwk | Wxrgv | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Wgcxdgdvhn | Kdv | $24.6 Bil | |
ALGN
| Align Technology Inc | Dtplksl | Ntmjmm | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Rzxlfzcxv | Yngjyjg | $18.7 Bil | |
PODD
| Insulet Corp | Bcbpvmlq | Gbxxnw | $11.5 Bil |